Jennifer French and James Cavuoto are editors and publishers for Neurotech Reports, a news source whose mission is to provide up-to-date information about the field of neurotechnology that impacts research and venture capital. In this episode, they discuss some updates and recent events happening within the last month in the industry of neurotechnology.

Top three takeaways:

1. The 2020 North American Neuromodulation Society Annual Conference was a very informative and successful conference, and the Emerging Technologies Forum hosted by Neurotech News had great attendance and presentations
2. Companies such as Medtronic are starting to capitalize on the use of glial cells in modulating pain networks
3. Neurotech Reports will be hosting the Bioelectronic Medicine Forum which focuses on both the research and financial realms of bioelectronic medicine and neurotechnology

[0:00] Ladan introduces the episode and the two guests, Jennifer French and James Cavuoto, who start by discussing the North American Neuromodulation Society Annual Conference in Las Vegas, NV

[3:40] French and Cavuoto discuss how large the event was and that it will likely take place again given the excellent turnout

[4:45] The role of glial cells in pain networks was a very significant discussion according to Cavuoto; Medtronic is capitalizing on this with a startup called Stimgenics that they have recently acquired

[6:45] A recent publication of Neurotech Business Report has discussed some failures of certain neurotech companies

[8:20] The 2020 Bioelectronic Medicine Forum hosted by Neurotech Reports will take place in New York City on April 7, 2020, and it hones in on the bioelectronic medicine aspect of neurotechnology

[10:40] Neurotech Reports has released an updated version of two whitepapers, one of which describes funding opportunities for startups, and one discusses venture capital funding